Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Tammy Miller has been a wealth and philanthropy advisor for over 30 years. As executive director of the Aldarra Foundation, ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Fred Hutch board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors ...

Rare secondary cancers occurred in patients receiving stem cell transplantation, but these were likely related to graft-versus-host disease and not to immune suppression conditioning.

Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees, nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential.